Pharma stocks fell yesterday after an early draft of House Speaker Nancy Pelosi’s plan to reduce drug prices was made public, which could curb prices on the 250 most expensive drugs.
President Donald Trump is preparing an executive order outlining a “favoured nations clause”, where US prices will reflect those in the country paying the least for their medicines.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
